Learn more

IMMUNISBIO CO LTD

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    99,014
  • Filing trend
    ⇩ 80.0%
About

IMMUNISBIO CO LTD has a total of 17 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and control are PLATELET BIOGENESIS INC, STEMON INC and IMMUNOPORATION LTD.

Patent filings in countries

World map showing IMMUNISBIO CO LTDs patent filings in countries

Patent filings per year

Chart showing IMMUNISBIO CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Jung Hwa 12
#2 Hwang Sung Hwan 11
#3 Moon Guy Young 3
#4 Lee Eui Soo 3
#5 Kim Sung Ho 3
#6 Lim Go Eun 3
#7 Choi Eun Young 3
#8 Hwnag Sung Hwan 2
#9 Choi Jin Kwan 2
#10 Jeong Sang Hun 1

Latest patents

Publication Filing date Title
KR102218211B1 Healing composition comprising regulatory T cell-conditioned media
KR102162727B1 Novel cell therapeutics composition by simultaneous administration of human cell-derived extracellular vesicles and cells
KR102096500B1 Doughnut-shaped cell culture bag and cell culture system with it
KR102111283B1 Shaking culture method of immune cells
KR102081418B1 A medium composition of regulatory t cells derived from peripheral blood mononuclear cells and cultivation method using the same
KR102036599B1 Training Kit for separating Peripheral Blood Mononuclear Cell
KR102051326B1 Apparatus for extracting cell
KR102075422B1 Tube for harvesting target cell and injection kit comprising the same
KR102081417B1 Use of BTO-1 for proliferating NK cells
WO2018110892A2 Method for mass proliferation of natural killer cells using macrophages and inflammatory substances
KR20180117829A Mass Propagation Method Of NK Cells
KR20180096947A Autometic and Asepsis Cell Culture Apparatus
WO2018110713A1 Massive proliferation method for natural killer cells using macrophages and inflammatory substances